Discusses the role of the advances in membrane technology and the manufacturing process in the redefined requirements for acceptable dialyzers for hemodialysis treatments. Assessment of biocompatibility; Microdomain in blood membrane interaction; Transmembrane transfer of endotoxins; Discussion on membrane charge.